Perspective Therapeutics, Inc announced that it has entered into an investment agreement in a private placement to issue 92,009,981 shares of its common stock at a price of $0.95 per share for a gross proceeds $87,409,481.95 on March 4, 2024. The private placement is expected to close on March 6, 2024, subject to the satisfaction of customary closing conditions. The transaction included participation from new investor Lantheus Holdings, Inc. for $57.4 million.